|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/46 | |
| A61K 9/00 | |||
| A61K 9/12 | |||
| A61P 11/00 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61M 15/00 |
| (11) | Number of the document | 3143998 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16185402.1 |
| Date of filing the European patent application | 2012-12-06 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161577315 P | 2011-12-19 | US | |
| 201200525 | 2012-01-13 | GB |
| (72) |
ZENG, Xian-Ming, US
|
| (73) |
Teva Branded Pharmaceutical Products R & D, Inc.,
41 Moores Road, Frazer, Pennsylvania 19355,
US
|
| (54) | AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM |
| AN INHALABLE MEDICAMENT COMPRISING TIOTROPIUM |